Results 241 to 250 of about 332,661 (303)

Diagnosis and Management of Prenatal Hereditary Pyropoikilocytosis

Prenatal Diagnosis, EarlyView.
ABSTRACT Hereditary pyropoikilocytosis (HPP) is a severe hemolytic anemia caused by variants in SPTA1, SPTB, and EPB41. These weaken horizontal interactions in the erythrocyte cytoskeleton, causing membrane fragmentation and splenic sequestration. It will readily cause fetal anemia and often hydrops fetalis. Prenatal diagnosis requires first ruling out
Connor Hartzell, Samantha Stover, Nora Gibson, Timothy Olson, James Connelly, Matthew Grace, Jennifer Andrews   +6 more
wiley   +1 more source

Extracorporeal Photopheresis for Chronic Graft-Versus-Host Disease According to 2014 NIH Consensus Criteria. [PDF]

J Clin Apher
Goretsky Y, Holtzman N, Han S, Reis IM, Suzuki V, Jean P, Mones K, Diaz-Paez M, Benjamin C, Beitinjaneh A, Goodman M, Jimenez AJ, Lekakis L, Pereira D, Spiegel J, Wu Y, Green DJ, Komanduri KV, Wang TP.   +18 more
europepmc   +1 more source

Current therapeutics for sclerotic and fibrotic manifestations of chronic graft-versus-host disease. [PDF]

Bone Marrow Transplant
Choe H, DeFilipp Z.
europepmc   +1 more source

Xenopax is effective for the treatment and prophylaxis of acute graft-versus-host disease. [PDF]

Blood Sci
Liu D.
europepmc   +1 more source

Ruxolitinib Plus Extracorporeal Photopheresis for Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease. [PDF]

J Clin Med Res
Halahleh K, Sultan I, Abu-Khader A, Al-Far R, Halahleh L, Abdel Rahman Z, Muradi I, Khattab E, Abu Jazar H.   +8 more
europepmc   +1 more source

Chronic graft versus host disease in upper limb: Calling upper limb rehabilitation specialists for improving outcomes in patients. [PDF]

Clin Hematol Int
Mohammed JA, Couthard C, AlGhamdi A, Ogbeivor C, Hashmi SK.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Graft-versus-Host Disease

New England Journal of Medicine, 1991
Graft-versus-host disease, both acute and chronic, continues to be the major complication of human bone marrow transplantation. Improved posttransplant chemoprophylaxis has reduced the incidence of acute graft-versus-host disease, but the incidence of the chronic form of the disease remains unchanged.
J L, Ferrara, H J, Deeg
openaire   +4 more sources